Cite
HARVARD Citation
Castenmiller, S. et al. (n.d.). 40P Can we predict which TIL products will react against NSCLC tumours based on the immune infiltrates?. Immuno-oncology technology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Castenmiller, S. et al. (n.d.). 40P Can we predict which TIL products will react against NSCLC tumours based on the immune infiltrates?. Immuno-oncology technology. p. . [Online].